Pretreatment PSA levels affects the completion rate of Ra-223 treatment

Abstract The aim of this study was to review our initial experience of using radium 223 (Ra-223) for metastatic castration-resistant prostate cancer (CRPC) and to evaluate whether pretreatment PSA levels correlate with completion of Ra-223 treatment. In addition, we examined change ratios of PSA, AL...

Descripción completa

Guardado en:
Detalles Bibliográficos
Autores principales: Nobuko Utsumi, Hiromasa Kurosaki, Kosei Miura, Hiroki Kitoh, Koichiro Akakura
Formato: article
Lenguaje:EN
Publicado: Nature Portfolio 2021
Materias:
R
Q
Acceso en línea:https://doaj.org/article/b21b6bec7d8547c9b0bee33a89f12746
Etiquetas: Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!